z-logo
open-access-imgOpen Access
MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS
Author(s) -
JongDae Lee,
Jin Hee Shin,
Sang Gil Hwang,
Byoung Joo Gwag,
Ann C. McKee,
Junghee Lee,
Neil W. Kowall,
Hoon Ryu,
DaeSik Lim,
EuiJu Choi
Publication year - 2013
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1300894110
Subject(s) - sod1 , amyotrophic lateral sclerosis , neurodegeneration , biology , kinase , microbiology and biotechnology , protein kinase a , autophagy , neuroscience , superoxide dismutase , medicine , oxidative stress , apoptosis , biochemistry , pathology , disease
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disorder characterized by loss of motor neurons. Dominant mutations in the gene for superoxide dismutase 1 (SOD1) give rise to familial ALS by an unknown mechanism. Here we show that genetic deficiency of mammalian sterile 20-like kinase 1 (MST1) delays disease onset and extends survival in mice expressing the ALS-associated G93A mutant of human SOD1. SOD1(G93A) induces dissociation of MST1 from a redox protein thioredoxin-1 and promotes MST1 activation in spinal cord neurons in a reactive oxygen species-dependent manner. Moreover, MST1 was found to mediate SOD1(G93A)-induced activation of p38 mitogen-activated protein kinase and caspases as well as impairment of autophagy in spinal cord motoneurons of SOD1(G93A) mice. Our findings implicate MST1 as a key determinant of neurodegeneration in ALS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom